YOLFTbeta
JPI Healthcare Co.,Ltd.

JPI Healthcare Co.,Ltd.

0010V0 · KQ · Healthcare / Medical Devices

7,640.00KRW+10.00 (+0.13%)

Price History

Full chart

Market Stats

Previous Close7,630.00
Open7,590.00
Day Range7,320.00 – 7,790.00
52-Week Range6,810.00 – 23,089.16
Volume2.20K
Market Cap44.67B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield2.87%
50-Day Avg8,772.80
200-Day Avg11,081.90

About

JPI Healthcare Co.,Ltd. manufactures and sells X-ray equipment and components worldwide. Its products include X-ray grids; X-ray film processors; digital radiography equipment; and other X-ray devices. The company also offers the Stretta System that provides physicians with an outpatient treatment for gastroesophageal reflux disease; and air cleaners. In addition, it trades in anesthesia machines, patient monitors, ultrasound imaging machines, automated TEE probe disinfectors, endoscopic RF treatment systems, stents, automatic X-Ray exposure controls, dose area product measuring systems, X-ray protective aprons, and Protect-A-Grid Panels. JPI Healthcare Co.,Ltd. was formerly known as Jungwon Precision Ind. Co., Ltd. and changed its name to JPI Healthcare Co.,Ltd. in January 2011. The company was incorporated in 1980 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jin Guk Kim
  • Headquarters608-ho 28, Seoul, South Korea, 08377, Korea
  • Websitehttps://www.jpi-korea.com

Leadership

  • Mr. Jin Guk KimCEO & Chairman · b. 1965
  • Mr. DongGeon YoonChief Financial Officer · b. 1976
  • Mr. PyungSik AhnHuman Resources Director · b. 1974
  • Mr. Kyungwoo KimDirector & Head of R&D Center · b. 1969

Financials

Income Statement

Currency: KRW2023-12-312024-12-312025-12-31
Total Revenue45.41B45.05B48.47B
Growth (%)--0.79%+7.58%
Cost of Revenue26.26B25.44B28.15B
Gross Profit19.15B19.62B20.32B
Gross Margin42.17%43.54%41.93%
Operating Expense12.58B15.68B15.46B
Operating Income6.57B3.94B4.86B
Operating Margin14.47%8.74%10.03%
EBITDA9.37B8.51B7.57B
EBITDA Margin20.64%18.90%15.62%
Net Income6.61B6.04B5.26B
Net Income Margin14.55%13.40%10.85%
R&D3.09B3.84B3.58B
R&D as % of Total Revenue6.81%8.52%7.39%
Interest Expense326.11M403.47M406.92M
Interest Expense % of Total Revenue0.72%0.90%0.84%

Balance Sheet

Currency: KRW2023-12-312024-12-312025-12-31
Total Assets53.61B65.85B82.38B
Total Liabilities16.25B24.48B19.33B
Total Equity36.91B41.45B63.53B
Cash6.84B8.47B7.36B
Net Debt1.20B6.87B3.84B

Cash Flow

Currency: KRW2023-12-312024-12-312025-12-31
Operating Cash Flow4.41B3.90B3.22B
Capital Expenditure754.24M11.30B1.17B
Free Cash Flow3.66B-7.40B2.05B
Dividends Paid1.12B1.46B1.44B
FCF to OCF82.91%-189.51%63.67%
Dividend Paid to FCF30.68%-19.68%70.16%

Earnings

Report DateSep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----
EPS Actual245.59336.55341.75454.13
Surprise----
Timing----

Key Statistics & Ratios

Market Cap44.67B
Enterprise Value22.25B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.95
Price / Book0.66
Revenue (TTM)46.86B
Gross Profit (TTM)19.72B
EBITDA6.33B
Profit Margin15.01%
Operating Margin17.96%
Return on Equity12.60%
Return on Assets3.92%
Shares Outstanding5.11M
Shares Float1.65M
Dividend Yield2.87%
Dividend Rate250.00
Payout Ratio18.14%

Dividends

20251×
250.00Dec 29, 2025